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Background: Since 2009, large-scale Streptococcus agalactiae infections have broken out in cultured tilapia farms in
China, resulting in considerable economic losses. Screening of the surface proteins is required to identify virulence
factors or protective antigens involved in piscine S.agalactiae infections in tilapia. Pre-absorbed immunoproteomics
method (PAIM) is a useful method previously established in our laboratory for identifying bacterial surface proteins.
Results: A serine-rich repeat protein family 1 (Srr-1), designated XF, was identified by PAIM in piscine S. agalactiae
isolate GD201008-001. To investigate the role of XF in the pathogenesis of piscine S. agalactiae, an isogenic xf
mutant strain (Δxf) and a complemented strain (CΔxf) were successfully constructed. The Δxf mutant and CΔxf
showed no significant differences in growth characteristics and adherence to HEp-2 cells compared with the
wild-type strain. However the 50% lethal dose of Δxf was increased (4-fold) compared with that of the parental
strain in a zebrafish infection model.
Conclusions: The findings demonstrated that XF is a virulence-related, highly immunoreactive surface protein and
is involved in the pathogenicity of S. agalactiae infections in fish.
Keywords: Streptococcus agalactiae, Piscine, Pre-absorbed immunoproteomic method (PAIM), Serine-rich repeat
protein (Srr), ZebrafishBackground
Streptococcus agalactiae, also referred to as Group B
Streptococcus (GBS), is a Gram-positive, β-hemolytic,
chain-forming coccus. It has been recognized as one of
the major causes of pneumonia and meningitis in neo-
nates [1], mastitis in cows [2], and meningoencephalitis
in fish [3]. Since 2009, serious piscine GBS infections
have occurred among tilapia farms in China, causing
high mortality and resulting in considerable economic
losses [4]. The isolate GD201008-001, a highly virulent
strain isolated from a moribund cultured tilapia in
China, was identified and sequenced in our laboratory in
2012 [5]. According to our comparative genomics ana-
lysis [6], isolates from cultured tilapia in China have a* Correspondence: lucp@njau.edu.cn; xup@ffrc.cn
1Key Laboratory of Animal Bacteriology, Ministry of Agriculture, Nanjing
Agricultural University, Weigang No.1, Nanjing 210095, Jiangsu, China
2Key Laboratory of Freshwater Fisheries and Germplasm Resources
Utilization, Ministry of Agriculture, Freshwater Fisheries Research Center,
Chinese Academy of Fishery Sciences, Wuxi 214081, China
© 2014 Liu et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.very close genomic relationship with the human strain
A909. In fact, the genomic content of these isolates can-
not be distinguished from that of A909. S. agalactiae
A909 was originally isolated from the cerebrospinal fluid
of a neonate with meningitis in the USA [7]; therefore,
S. agalactiae infections among fish in China may repre-
sent a zoonotic hazard although further investigations
are required to confirm this hypothesis.
As a consequence of the potential economic and eco-
logical impacts on public health, many studies have been
conducted on S. agalactiae with the aim of identifying
virulence factors [8], diagnostic markers [9,10] and treat-
ments [11]. Surface proteins of pathogenic bacteria are
known to mediate the key step in the bacteria-host inter-
action during infection and may represent protective an-
tigens and virulence markers. Thus, identification of S.
agalactiae surface proteins associated with bacterial
infection and a greater understanding of their roles in
pathogenicity are required. The pre-absorbed immuno-
proteomics method (PAIM) was successfully establishedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in our previous study [12,13] and has been applied in
Escherichia coli [14] and Campylobacter jejuni [15]. This
technique involves the separation of proteins by two-
dimensional electrophoresis (2-DE) and Western blot-
ting with untreated (hyperimmune rabbit serum) and
“pre-absorbed” serum, which is produced from untreated
serum using a modified cross-absorption process to re-
move bacterial surface antigen-specific antibodies. Pro-
tein spots that appear in the blot probed with untreated
sera, but that are absent in the blot probed with pre-
absorbed sera, are assumed to be surface proteins.
In this study, we performed PAIM analysis of the pis-
cine S. agalactiae strain GD201008-001 and identified a
serine-rich repeat protein (Srr-1), designated XF, among
the potential surface proteins. Previous research has in-
dicated that Srr-1 is an important surface protein for ad-
herence and virulence in human S. agalactiae strains
[16,17]. However, the role of Srr-1 in the pathogenicity
of piscine S. agalactiae is unknown. To investigate this
issue, a mutant strain (Δxf ) and a complemented strain
(CΔxf ) were constructed using streptococcus-E. coli shut-
tle vectors pSET4s [18] and pSET2 [19]. Their growth
characteristics, adherence to HEp-2 cell and virulence
were evaluated in a zebrafish infection model.
Results and discussion
Pre-absorbed immunoproteomics on S. agalactiae
Untreated and pre-absorbed antisera were used to probe
2-DE blots of S. agalactiae GD201008-001 cell lysates.
The immunoreactive spots observed in immunoblots
(Figure 1B and C) were matched with the corresponding
protein spots observed in the stained 2-DE gel (Figure 1A)
by comparison using the layer function of Photoshop CS.
In order to minimize the proteomics trial error, the experi-
ments were repeated at least in triplicate, and only the
highly reproducible spots were selected. One spot, XF, that
invariably appeared in the blot probed with untreated
serum (Figure 1AB), but was less distinct in the blot
treated with pre-absorbed serum (Figure 1AC) in the trip-
licate repeat tests, was excised from preparative 2-DE gels,
subjected to tryptic digestion, and then analyzed by
matrix-assisted laser desorption ionization-time of flight
mass spectrometry (MALDI-TOF MS) and the PSORT
program. Other spots which were not detected using the
pre-absorbed serum in repeat experiments were also ex-
cised and analyzed by MALDI-TOF MS; however, these
proteins were predicted to be cytoplasmic by the PSORT
program (data not shown).
Because of the much greater sensitivity of western
blotting, the XF spot was more extensive in these blots
than in the paired Coomassie brilliant blue G-250
stained gels. Consequently, low abundance proteins with
strong immunoreactivity, such as XF, are stronglystained in western blotting analyses. In addition, the
serine-rich repeat proteins of S. agalactiae have been re-
ported to be high MW glycoproteins (300–400 kDa) due
to glycosylation [17,20], although their genes encode just
654–1,326 amino acids. In the present study, the appar-
ent molecular weight of XF was in the 150 kDa range. It
can be speculated that the large disparity between the
published reports and our result is due to differences in
the degree of glycosylation of serine-rich repeat proteins.
Furthermore, one of the limitations of 2-DE is the inabil-
ity to analyze very large (MW >200 kDa) or very small
(MW <10 kDa) proteins [21]. Consequently, fully glyco-
sylated serine-rich repeat proteins (MW >300 kDa) will
not be detected in 2-DE.
The Srr-1 protein from piscine and human S. agalatiae
strains
Spot XF was identified as a cell wall surface anchor
family protein (gi|406709853) by MALDI-TOF MS
(Additional file 1), also known as a serine-rich repeat
protein (Srr-1) [22]. It has been confirmed that Srr-1 is
localized on the surface of streptococcal cells and binds
to human fibrinogen and keratin [23]. Previous immuno-
proteomics studies have confirmed that Srr-1 is a highly
immunoreactive protein that is reactive with both S.
agalactiae convalescent guinea pig sera and infected til-
apia antisera [24]. The conserved domain architecture
retrieval tool of NCBI (Figure 2) showed that the Srr-1
protein has an orthologous counterpart among GBS
strains: a long and specialized signal sequence, two exten-
sive serine-rich repeat regions (SRR1, 2) that undergo gly-
cosylation, a fibrinogen-binding domain (SdrG), which is
necessary for binding to human fibrinogen and keratin 4
[23], and a typical LPXTG cell wall anchoring motif. The
Srr-1 proteins range in size from 654 aa to 1,326 aa and
the C-terminal SAS (T/M) repeat region (SRR2) is respon-
sible for the observed size variation, which has also been
reported previously by Samen et al. [16]. Blastp analysis
showed that the similarity of the amino acid sequence of
Srr-1 proteins from 1 aa to 643 aa (containing a SdrG) is
greater than 90%, and 100% identical among piscine
strains GD201008-001 and ZQ0910 and human strains
A909 and CJB111. Protein XF contains 974 aa, with a
SdrG region between 472–629 aa and a SRR2 region from
698–974 aa. In piscine S. agalactiae SA20-06, the Srr-1
protein is only 654 aa and devoid of SRR2 due to a single
base (A) deletion at the position 1,917 bp in its ORF lead-
ing to early termination. In the study by Takahashi et al.
[25], the predicted secondary structures of Srr proteins
from S. agalactiae are similar to those of Srr proteins from
other streptococcal species. Using the SWISS-MODEL
tool, we found that the predicted secondary structures of
Srr-1 proteins among S. agalactiae were similar, even
when compared with strain SA20-06.
Figure 1 Pre-absorbed immunoproteomics on picsine S. agalactiae GD201008-001. (A) GD201008-001 total cell proteins (pH 4–7, 13 cm),
stained with Coomassie brilliant blue G-250. (B) 2-DE blot of GD201008-001 proteins probed with untreated antiserum. (C) 2-DE blot of GD201008-001
proteins probed with “pre-absorbed” antiserum. (AB) Merge of layers A and B. In Photoshop CS, the duplicated gel layer A was used as the background
layer and the western blotting layer B as the surface layer in 50% transparency. (AC) Merge of layers A and C. In Photoshop CS, the duplicated gel layer
A was used as the background layer and the western blotting layer C as the surface layer in 50% transparency.
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To further investigate the function of protein XF in the
pathogenesis of piscine S. agalactiae, the plasmids
pSET4s-XF and pSET2-CΔxf were constructed as xf
gene deletion (Figure 3) and complementation mutants,
respectively.
The pSET4s-XF and pSET2-CΔxf plasmids were veri-
fied to be correct by diagnostic restriction enzyme diges-
tion with SalI/SmaI and BamHI/PstI, respectively
(Figure 4A). The mutant strains Δxf and CΔxf were con-
firmed by PCR (Figure 4B) and real-time PCR (Figure 5).
The primers XF A and D amplified a 1,377 bp fragment
of the Δxf, while no product was generated from the
parental and complementation templates. The XF1/XF2
primers amplified a 289 bp product from the parental
GD201008-001 and CΔxf templates while no product was
obtained from the Δxf template. All the PCR products ob-
tained had the expected fragment sizes (Figure 4B) and in
correct sequence.
To confirm that the mutant has no effect on the tran-
scription of bilateral genes, qRT-PCR assays was per-
formed to detect the expression of xf gene, xf upstream
and downstream ORF genes in the parental, mutant and
complementation strains. Data for the three strains were
normalized to the expression of the GAPDH gene usingthe 2−ΔΔCTmethod. The transcription levels of xf gene in
the Δxf were below the level of detection for this assay
and there were no significant differences in xf upstream
and downstream gene transcription levels between Δxf
and CΔxf (P >0.05; Figure 5). These results indicated the
successful construction of an isogenic knockout mutant
of xf and complementation of Δxf, with no effects on the
transcription of bilateral genes. The transcription level
of xf in the CΔxf strain replicated from plasmid pET-2
was higher than that replicated from the genome of the
wild-type strain (Figure 5) due to the increased plasmid
copy number compared to the genome replication num-
ber, with each new cell acquiring at least one copy of the
plasmid as the cell divides. Moreover, the plasmid pET-2
was constructed from pSSU1, a native plasmid isolated
from S. suis DAT1 [19] and belonging to the pMV158
plasmid family [26]. Lorenzo-Diaz et al. showed that the
number of copies of the pMV158 vector was lower in
enterococci (around 17 copies per genome equivalent)
than that in pneumococci (around 30 copies) [27].
Growth characteristics of the mutant and
complementation strains
Before studying the effect of XF inactivation on the
pathogenesis of S. agalctiae in vivo, it is important to
Figure 2 Alignment of the Srr-1 proteins from piscine, bovine and human S. agalatiae strains. Alignment was performed using conserved
domain architecture retrieval tool on NCBI. SP: signal peptide; SRR1: serine-rich repeat domain 1; SdrG: fibrinogen-binding domain; SRR2: serine-
rich repeat domain 2.
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mutant and complementation strains in vitro. The
OD600 of cultures of the GD201008-001 and Δxf strains
in TSB broth and CΔxf in TSB broth containing
100 μg/mL spectinomycin at 37°C were determined. In
addition, the growth curves of these strains at 28°C were
also determined for evaluation of the LD50 values in a
zebrafish infection model at 28°C. As shown in Figure 6,
there were no significant differences in the growth curves
of the wild-type, Δxf and CΔxf strains at the same
temperature. The bacterial population reached a peak dur-
ing the logarithmic growth phase after 6 h at 37°C andFigure 3 Schematic representation of construction of xf mutant in S. a
chromosomal structures before (left) and after (right).after 10 h at 28°C. Moreover, no differences in shape and
chain formation were observed between the strains follow-
ing Gram staining (data not shown).
Contribution of XF to adhesion and invasion in vitro
To investigate the importance of XF for bacterial adher-
ence to, and invasion of host cells, the human epithelial
cell line HEp-2 was infected in vitro with the parental,
mutant and complementation strains under the same
conditions in triplicate repeat tests. As shown in Figure 7,
the adherence of the GD201008-001 wild-type strain to
HEp-2 cells was only 0.4% with a multiplicity of infectiongalactiae GD201008-001 by allelic exchange. Representation of the
A B
Figure 4 Restriction enzyme digestion identification of
recombinant plasmids (A) and PCR confirmation of knockout
mutant strain Δxf (B). Lane 1: pSET4S-xf plasmid enzyme digestion;
Lane 2: pSET2-CΔxf plasmid enzyme digestion; Lane 3: primers XF
A/D, GD201008-001; Lane 4: primers XF A/D, ΔXF; Lane5: primers XF
A/D, CΔxf; Lane 6: primers XF 1/2, GD201008-001; Lane 7: primers
XF1/2, Δxf; Lane 8: primers XF 1/2, CΔxf; M: Marker DL5000.
Figure 6 Growth curve of S. agalactiae GD201008-001 and its
derivatives at 37°C and 28°C.
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in the adherence to HEp-2 cells among the GD201008-
001, Δxf and CΔxf strains (P >0.05). In the invasion
assays, the parental strain GD201008-001 displayed
poor invasion of HEp-2 cells (<0.0005%) and there
were no significant differences in corresponding activ-
ity exhibited by the Δxf and CΔxf strains (data not
shown). These results indicate that piscine S. agalac-
tiae GD201008-001 has weak capacity for adherence to
and invasion of HEp-2 cells. Thus, XF has almost no
effect on bacterial adherence and invasion to HEp-2
cells under the chosen experimental conditions.Figure 5 Transcription level of XF upstream, downstream and
XF self open-reading frames between the wild-type and its
derivatives in vitro. The value of xf associated genes in the wild-type
is set as 1.0. The relative change in the gene transcription ratios of
the selected genes was normalized to the transcription of a single
housekeeping gene (GAPDH gene), and calculated as by the 2–ΔΔ CT
method. Data are representative of three independent experiments
carried out in triplicate. Error bars indicate standard deviations.The study by Samen et al. showed that Srr-1 could not
mediate bacterial invasion into HEp-2 cells, but pro-
moted adherence of the S. agalactiae human strain 6313
to HEp-2 cells [16]. Compared with our results, Srr-1
showed a different effect on adherence to Hep-2 cells
between human and piscine strains. Since piscine S. aga-
lactiae GD201008-001 showed only weak adhesion cap-
ability to HEp-2 cells, this cell line may not the best
choice for investigation of the cell adhesion capacity of
piscine S. agalactiae. The contribution of XF to adhesion
and invasion in vitro was not clearly reflected under these
experimental conditions; therefore, development of anFigure 7 Effects of xf on S. agalactiae adherence to HEp-2 cells
(MOI: 10). Data are representative of three independent
experiments carried out in triplicate. Error bars indicate
standard deviations.
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required for more accurate evaluation of the adhesion cap-
ability of piscine bacteria in vitro. It can be speculated that
the poor capacity of the piscine strain for adherence to
and invasion of HEp-2 cells is the result of the loss of some
genes nonessential genes involved in adherence to human
cells during adaptation to the fish host. For example, there
are no lmb or scpB genes derived from the genomes of pis-
cine S. agalactiae strains in the NCBI nr database to date
[28]. These two genes encode two important adhesins in
human strains: laminin-binding protein and C5a peptidase,
respectively [29,30].
Virulence of wild-type and Δxf strains in a zebrafish
infection model
The zebrafish infection model was used to estimate the
effect of the XF mutation on S. agalactiae virulence.
This model has already been established for multiple
streptococcal infections, including Streptococcus pyogenes
[31], Streptococcus pneumonia [31], Streptococcus suis [32]
and Streptococcus agalactiae [33]. Zebrafish have many ad-
vantages for this purpose, such as the existence of both in-
nate and adaptive immune systems, short generation time,
ease of breeding large numbers in the laboratory and suit-
ability for large-scale genetic screens. Zebrafish were
injected intraperitoneally (i.p.) with either the parental
GD201008-001, Δxf or CΔxf strains at various doses in
triplicate repeat tests. The mortality of zebrafish was ob-
served within 7 days post-challenge. As shown in Figure 8,
the average LD50 values determined in triplicate assays
were 2.3 × 102 CFU/zebrafish for the wild-type strain,
8.6 × 102 CFU/zebrafish for Δxf, and 3.3 × 102 CFU/zebra-
fish for CΔxf. The 50% lethal dose of Δxf was increased (4-
fold) compared with that of the parental strain while thatFigure 8 LD50 of wild-type, mutant and complementation
strains in the zebrafish infection model.of the complementation strain CΔxf was restored to 0.4-
fold higher than that of the mutant strain Δxf. These re-
sults indicate a significant reduction in the virulence of S.
agalactiae in the Δxf mutant strain (P <0.05).
Conclusions
In this study, a serine-rich repeat protein family 1 (Srr-
1), designated XF, was identified by PAIM in the piscine
S. agalactiae isolate GD201008-001. The effect of the XF
protein on the virulence of piscine S. agalactiae in zeb-
rafish was significant despite its low adherence to the
human epithelial cell line Hep-2. In conclusion, our
study indicates the involvement of Srr-1 in the virulence
of S. agalactiae in fish.
Methods
Bacterial strains, plasmids and growth conditions
Streptococcus agalactiae strain GD201008-001 was iso-
lated from a moribund cultured tilapia with meningo-
encephalitis in the Guangdong Province of China in
2010 [5]. The strain was grown in trypticase soy broth
(TSB, Oxoid) at 37°C. Escherichia coli DH5α was supplied
by Tiangen (Beijing, China). The streptococcus-E.coli
shuttle vectors pSET4s and pSET2 were donated by Dr.
Takamatsu from the Laboratory of Molecular Bacteriology,
National Institute of Animal Health, Ibaraki, Japan. E. coli
strains were maintained in Luria–Bertani (LB) broth at
37°C. Antibiotics (Sigma) were added to culture media as
required at the following concentrations: ampicillin, 50 μg/
mL for E. coli; spectinomycin, 100 μg/mL for S. agalactiae,
50 μg/mL for E. coli. Bacteria were stored as frozen cul-
tures at −20°C in either TSB or LB, containing 25% (v/v)
glycerol. All the strains and plasmids used in this study
were showed in Table 1.
Pre-absorbed immunoproteomics method
Precipitation of bacterial proteins
GD201008-001 total cell protein precipitations were per-
formed as described previously [24]. Briefly, 30 mL ex-
ponential growth cultures were centrifuged at 10, 000 × g
for 15 min at 4°C and washed twice in PBS. Pellets were
resuspended in Mutanolysin working buffer (30 mM
Tris–HCl, 3 mM MgCl2, 25% sucrose) containing 125U/
mL Mutanolysin (Sigma) and incubated for 90 minutes
at 37°C. The components of solution B (7 M urea, 2 M
thiourea, 4% CHAPS, and 65 mM DTT; GE Healthcare)
were added directly into the mixed solution. The turbid
solution gradually became transparent and was then
sonicated in an ice bath for 50 cycles of 5 s on/10 s off
at 100 W. After 30 min incubation at 25°C, unbroken
cells was removed by centrifugation at 10,000 × g for
15 min at 4°C. Proteins in the supernatant were precipi-
tated in 10% pre-chilled trichloroacetic acid (TCA) and
incubated in ice-water for 30 min. After centrifugation




GD201008-001 Virulent strain of piscine S.agalactiae isolated in China Collected in our
laboratory
Δxf Mutation in xf gene of GD201008-001 In this study
CΔxf Complemented strain of Δxf; SpcR In this study
E. coli DH5a Cloning host for maintaining the recombinant plasmids Invitrogen
Plasmids
pSET4s vector Temperature-sensitive Streptococcus-E. coli shuttle vector pSET4s; 4506 bp; SpcR [18]
pSET2 vector Streptococcu- E. coli shuttle vector pSET2; 5016 bp; SpcR [19]
Primers
XF A CGCGTCGACGAAGTTGTAAAGCGTTTG In this study
XF B TTTGGACATGTTTCCTCC, amplifies the flank sequence upstream xf coding sequence (665 bp)
XF C GGAGGAAACATGTCCAAAAAAGACTAAACCTACTTT
XF D TCCCCCGGGCCGAACGATTATACAT; amplifies the flank sequence downstream xf coding
sequence (712 bp)
C XF F AAACTGCAGACACAACTCCTTTCACTCATT
C XF R CGCGGATCCGGCTTTTTACAAACTTCTACA; amplifies the structural gene of the xf gene,
including its own promoter (3407 bp)
XF 1 AATGATTGCAAGCGATA
XF 2 GTTAACAGAAGCGATTGA; amplifies the fragment inside the xf gene(289bp)
RT-PCR Primers
GAPDH-F GATGACTACTATCCACGCATACAC In this study
GAPDH-R TGCAGCACCAGTTGAGTTAG
XF up F CCTGTGTTGGAGTGAAGATAGAG
XF up R CCAGCAGCCAAGAAAGTAGATA
XF self F CTTGCAGAACAAACGGAAGTG
XF self R TGAGGCTGACTCTGACATAGA
XF down F CTCGTTCTTCTGTCTATCGTCTG
XF down R ATGCGATATTCGTCACCTACAA
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pended in 10 mL of pre-chilled acetone and washed
twice. The final pellet was dried in air.
Isoelectric focusing (IEF)
IEF was performed using the Ettan IPGphor-3 IEF sys-
tem (GE Healthcare) with 13 cm (Immobiline DryStrip,
pH 4–7; GE Healthcare) gel strips. Prior to rehydration,
the precipitated proteins were treated using the 2-D
Clean-up Kit (GE Healthcare) to remove contaminants
that interfere with electrophoresis. IPG strips were rehy-
drated overnight at room temperature (RT) with rehy-
dration solution (7 M urea, 2 M thiourea, 2% CHAPS,
0.2% DTT, 0.5% IPG buffer (pH 4–7), and 0.002% Bro-
mophenol blue. Each strip was loaded with 200 μg of
protein and IEF was carried out at 20°C for 12 h (max-
imum voltage of 8,000 V, maximum current of 50 μA/
IPG strip, total 28,000 Vh).2D SDS-PAGE
Prior to 2D SDS-PAGE, each IPG strip was washed in
equilibration buffer 1 (375 mM Tris–HCl pH 8.8, 6 M urea,
2% SDS, 2% DTT) for 15 min followed by equilibration buf-
fer 2 (375 mM Tris–HCl pH 8.8, 6 M urea, 2% SDS, 2.5%
iodoacetamide) for 15 min. Each IPG strip plus a SDS-
PAGE Molecular Weight Standard (Invitrogen) was loaded
on a homogeneous 12% polyacrylamide gel and sealed with
1% agarose. Electrophoresis was performed at 15°C with an
initial voltage of 110 V for 30 min, followed by 220 V until
the tracking dye reached the gel bottom. All gels were
stained with Coomassie brilliant blue G-250 according to
the manufacturer’s instructions (GE Healthcare). Each 2D
IEF/SDS-PAGE experiment was repeated three times.
Preparation of hyperimmune sera and “pre-absorbed” sera
Rabbits were first confirmed to be negative for S.
agalactiae antibodies using an indirect enzyme-linked
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Subsequently, these rabbits were immunized with
formaldehyde-inactivated S. agalactiae GD201008-001
using Montanide ISA 206 VG (SEPPIC Co. Ltd.) as the ad-
juvant. Two doses of 1.0 × 109cells/rabbit were adminis-
tered by intramuscular injections at 3-week intervals. Sera
from immunized rabbits were collected before the first
and after the second immunizations. The antibody titers of
the sera were evaluated by indirect ELISA.
The absorption protocol used was as described by Mittal
et al. [34]. Briefly, exponential cultures of S. agalactiae
GD201008-001 were centrifuged at 3,000 × g for 15 min at
4°C, and then washed twice in PBS. A total of 1.0 × 109
bacteria were suspended in 100 μL of GD201008-001
hyperimmune serum, incubated for 2 h at 37°C, and then
overnight at 4°C. Bacteria were pelleted by centrifugation
at 10,000 × g for 30 min. The supernatant was collected
and used as the “pre-absorbed” serum in Western blotting
analyses.
Western blotting
The protein samples from each SDS-PAGE gel were
transferred onto PVDF membranes (GE Healthcare)
using a semi-dry blotting apparatus (TE77, GE Health-
care) for 2 h at 0.65 mA/cm2. The membrane was then
blocked with 5% (w/v) skimmed milk in 50 mM Tris–
HCl buffer (pH 7.4) containing 0.05% Tween 20 (TBST)
for 2 h at RT. The blocked membrane was then incu-
bated with GD201008-001 hyperimmune serum or “pre-
absorbed” serum (1: 200 dilution) for 2 h at RT and
washed three times with TBST (10 min per wash). The
membrane was incubated with HRP-goat anti rabbit IgG
(1:10,000 dilution; Boster) at RT for 1 h, washed three
times with TBST, and developed by adding DAB (Tian-
gen) until the optimum color was obtained. Western
blotting was repeated in triplicate.
MALDI-TOF MS and database searching
Proteins identified from the 2-DE blots as potential surface
proteins were excised from duplicate SDS-PAGE gels and
subjected to in-gel trypsin digestion and MALDI-TOF MS
analysis (TOF Ultraflex II mass spectrometer, BrukerDal-
tonics). Peptide mass fingerprinting data (PMF) were ana-
lyzed using the MASCOT server (www.matrixscience.com).
MASCOT searches were used to identify significant pep-
tides and for determination of the combined peptide scores.
The extent of sequence coverage, number of matched pep-
tides, and the score probability obtained from the PMF data
were all used to validate protein identification. Low-scoring
proteins were either verified manually or rejected.
Bioinformatics analysis
Sequences of the identified proteins were searched using the
BLASTX server (http://www.ncbi.nlm.nih.gov/BLASTX/) toidentify homologous sequences. The PSORT server (http://
www.psort.org/) program was used to predict protein sub-
cellular localizations.
Construction of the mutant Δxf
Two DNA fragments flanking the xf gene were amplified
by PCR from the genome of GD201008-001 with the
primers XF A/B and primers XF C/D with incorporated
SalI and SmaI restriction enzyme sites, respectively in
primers A and D (Table 1). The resulting PCR products
were mixed in equal amounts and subjected to a crossover
PCR to generate a single PCR product. The crossover PCR
product and the temperature-sensitive streptococcus-E.
coli shuttle vector pSET4s were digested with appropriate
enzymes, ligated and used to transform E. coli DH5α. The
resulting pSET4S-XF plasmid was introduced into compe-
tent S. agalactiae GD201008-001 cells by electroporation
at 2.35 KV, 200Ω and 25 μF.
The procedure for the selection of mutants generated by
allelic exchange via double-crossover was performed as de-
scribed previously [18] with some modifications. In the
presence of the appropriate antibiotics, the temperature-
sensitive plasmid can be propagated in E. coli at 37°C, while
its replication is blocked in Streptococcus above 37°C. After
electroporation, S. agalactiae containing the pSET4S-xf
plasmid were first grown at 28°C in THY (THB supple-
mented with 2% yeast extract) for 4 h to recover, and then
cultured in THY containing 100 μg/mL spectinomycin to
mid-logarithmic growth phase. The pSET4S-xf plasmid in
S. agalactiae duplicated well in the appropriate antibiotics
at 28°C. The cells were then diluted and plated on TSB
containing 100 μg/mL spectinomycin and cultured at 37°
C. When the temperature increased from 28°C to 37°C,
the replication of this vector in S. agalactiae is blocked im-
mediately and the bacteria without the pSET4S-xf plasmid
are killed by spectinomycin. Thus, at the non-permissive
temperature (37°C) under antibiotic pressure, most of bac-
teria were destroyed and only a few survived by integrating
the pSET4S-xf plasmid genes into their own chromosome
by allelic exchange via single crossover recombination.
The single bacterial colony on the 100 μg/mL spectino-
mycin TSB plate cultured at 37°C was transferred to 28°C
in TSB liquid without antibiotics. These conditions forced
loss of the spectinomycin-resistance gene in their chromo-
some by allelic exchange. During the complete procedure,
the chromosomal xf gene of S. aglactiae was replaced by a
total double-crossover event (Figure 3). The identity of the
correct Δxf mutants was confirmed by PCR using XF A/D,
XF1/2 primers and DNA sequencing of the PCR product.
Functional complementation of Δxf
The xf gene, including its own promoter, was amplified
from the chromosomal DNA of GD201008-001 by PCR
using the primers C XF F and C XF R (Table 1). The PCR
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BamHI/PstI digested pSET2 [19] to generate the recom-
binant plasmid pSET2-CΔxf. The identity of the correct
pSET2-CΔxf vector was confirmed by sequencing using
the primers C XF F and C XF R. The pSET2-CΔxf plasmid
was then used to electrotransform the Δxf mutant to cre-
ate the complemented strain of ΔXF (designated CΔxf) on
THB agar under spectinomycin selection pressure.
Quantitative real-time reverse transcription PCR (qRT-PCR)
S. agalactiae strains GD201008-001, Δxf, CΔxf were cul-
tured overnight in TSB at 37°C and isolated RNA with an
E.Z.N.A.™ Bacterial RNA isolation kit (OMEGA, Beijing,
China). The cDNA synthesis was performed using the
PrimeScript™ RT reagent kit with DNA eraser (TaKaRa,
Dalian, China) according to the manufacturer’s instruc-
tions. The mRNA levels were measured using two-step
relative qRT-PCR. The glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) housekeeping gene was amplified
as an internal control. The specific primers used for the
various RT-PCR assays are listed in Table 1. The SYBR
Green PCR method was performed using the AceQ™ qPCR
SYBR™ Green Master Mix (Vazyme Biotech Co., Ltd.).
Reactions were carried out in triplicate and repeated three
times. An ABI 7300 RT-PCR system (Applied Biosystems)
was used for relative qRT-PCR. Dissociation analysis of
amplification products was performed at the end of each
PCR to confirm that only one PCR product was amplified
and detected. The comparative cycle threshold method
(2−ΔΔCTmethod) [35] was used to analyze the mRNA levels.
Growth characteristics of mutant strains
The wild-type strain GD201008-001, mutant strain Δxf
and the complementation strain CΔxf were separately
inoculated into flasks containing 100 mL TSB media,
and incubated at 37°C and 28°C. Samples of culture were
monitored at 1 h intervals for 13 h using a spectropho-
tometer (Bio-Rad, USA) at an absorbance of 600 nm.
The un-inoculated TSB served as the blank control. The
experiments were repeated twice.
Cell adherence assay
The cell adherence and invasion assay was performed as
previously described [36]. Briefly, the human laryngeal
cell line HEp-2 cells was cultured in RPMI 1640
media (Invitrogen, USA) in 24-well tissue culture
plates, supplemented with 10% fetal calf serum (FCS), and
maintained at 37°C in a 5% CO2 humidified incubator.
The wild-type strain GD201008-001, mutant strain Δxf
and complementation strain CΔxf were cultured separately
in TSB medium to the logarithmic phase and diluted to
the appropriate density to give a MOI of 10 in RPMI 1640
medium (without FCS). The monolayers were washed by
RPMI 1640 medium (without FCS) and incubated withdiluted bacteria. The plates were centrifuged at 800 × g for
10 min at RT before incubation for 2 h at 37°C. After incu-
bation, the medium was removed from each well and
monolayers were washed five times using PBS (pH 7.4).
For the cellular invasion assay, the extracellular bacteria
were eliminated by additional incubation of the mono-
layers with experimental medium containing gentamicin
(100 μg/mL) for 120 min at 37°C and the plate was washed
five times using PBS. HEp-2 cells were detached from
plates by treatment with 100 μL of 0.25% trypsin–0.1%
EDTA prepared in PBS (pH 7.4). The cells were lysed by
the addition of 900 μL ddH2O and appropriate dilutions
were plated on TSB agar plates for enumeration of the
bacteria adhering or invading to HEp-2 cells. Negative
control wells containing only cells were used in all experi-
ments. All assays were performed in triplicate and re-
peated at least three times.Animal experiments
The feeding and care of zebrafish supplied by the Pearl
River Fishery Research Institute of the Chinese Academy
of Fishery Science were performed as described by Neely
et al. [31]. The virulence of streptococcus was evaluated in
a zebrafish model as described previously [32]. Specifically,
50% lethal doses (LD50) were ascertained to determine the
differences in virulence between the wild-type and mutant
strains [33]. Prior to inoculation of fish, cultures (S. agalac-
tiae strains GD201008-001, Δxf and CΔxf) were collected,
cultured at 37°C to the logarithmic growth phase, washed
twice in TSB and adjusted to the appropriate doses (CFU/
fish). Zebrafish were anesthetized with tricaine methane-
sulfonate (MS-222) (Hangzhou Animal Medicine Factory)
at a concentration of 80 mg/L. The bacterial dose (CFU)
contained in the injected inoculum was confirmed at the
time of infection by plating onto TSB agar. Control fish
were injected with TSB. Fifteen fish were used to test
each dose. Mortality was monitored until 7 days post-
infection. The experiment was repeated three times and
the results were used to calculate the LD50 values using
the method of Reed and Muench [37]. The experi-
mental animal use license for the zebrafish studies was
approved by the Science and Technology Agency of
Jiangsu Province (China).Statistical analyses
All the statistical analysis was performed using SPSS ver-
sion 17.0 (SPSS Inc., Chicago, IL). Differences between the
mean values among groups was first evaluated by one-way
analysis of variance (ANOVA) and then by pairwise com-
parison of the mean values between the two groups,
followed by Tukey’s student rank test. Differences with a
P-value of <0.05 were considered significant, and a P-value
of <0.001 was considered highly significant.
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